1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Middle East & Africa ELISA Diagnostics Tests Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Middle East & Africa ELISA Diagnostics Tests Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Middle East & Africa ELISA Diagnostics Tests Market Regional Analysis
6.2 Middle East & Africa ELISA Diagnostics Tests Market Revenue 2020-2030 (US$ Million)
6.3 Middle East & Africa ELISA Diagnostics Tests Market Forecast Analysis
7. Middle East & Africa ELISA Diagnostics Tests Market Analysis – by Adoption
7.1 Human
- 7.1.1 Overview
- 7.1.2 Human: Middle East & Africa ELISA Diagnostics Tests Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.2 Veterinary
- 7.2.1 Overview
- 7.2.2 Veterinary: Middle East & Africa ELISA Diagnostics Tests Market – Revenue and Forecast, 2020-2030 (US$ Million)
8. Middle East & Africa ELISA Diagnostics Tests Market Analysis – by Test Type
8.1 Sandwich ELISA
- 8.1.1 Overview
- 8.1.2 Sandwich ELISA: Middle East & Africa ELISA Diagnostics Tests Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.2 Indirect ELISA
- 8.2.1 Overview
- 8.2.2 Indirect ELISA: Middle East & Africa ELISA Diagnostics Tests Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.3 Competitive ELISA
- 8.3.1 Overview
- 8.3.2 Competitive ELISA: Middle East & Africa ELISA Diagnostics Tests Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.4 Multiple & Portable ELISA
- 8.4.1 Overview
- 8.4.2 Multiple & Portable ELISA: Middle East & Africa ELISA Diagnostics Tests Market – Revenue and Forecast, 2020-2030 (US$ Million)
9. Middle East & Africa ELISA Diagnostics Tests Market Analysis – by Application
9.1 Autoimmune Diseases
- 9.1.1 Overview
- 9.1.2 Autoimmune Diseases: Middle East & Africa ELISA Diagnostics Tests Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.2 Infectious Diseases
- 9.2.1 Overview
- 9.2.2 Infectious Diseases: Middle East & Africa ELISA Diagnostics Tests Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.3 Cancer Diagnosis
- 9.3.1 Overview
- 9.3.2 Cancer Diagnosis: Middle East & Africa ELISA Diagnostics Tests Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.4 Protein Quantification
- 9.4.1 Overview
- 9.4.2 Protein Quantification: Middle East & Africa ELISA Diagnostics Tests Market – Revenue and Forecast, 2020-2030 (US$ Million)
10. Middle East & Africa ELISA Diagnostics Tests Market Analysis – by End User
10.1 Hospitals & Diagnostic Centers
- 10.1.1 Overview
- 10.1.2 Hospitals & Diagnostic Centers: Middle East & Africa ELISA Diagnostics Tests Market – Revenue and Forecast, 2020-2030 (US$ Million)
10.2 Pharmaceutical & Biotechnology Companies
- 10.2.1 Overview
- 10.2.2 Pharmaceutical & Biotechnology Companies: Middle East & Africa ELISA Diagnostics Tests Market – Revenue and Forecast, 2020-2030 (US$ Million)
10.3 Veterinary Hospitals & Diagnostic Laboratories
- 10.3.1 Overview
- 10.3.2 Veterinary Hospitals & Diagnostic Laboratories: Middle East & Africa ELISA Diagnostics Tests Market – Revenue and Forecast, 2020-2030 (US$ Million)
11. Middle East & Africa ELISA Diagnostics Tests Market – Middle East and Africa Analysis
11.1 Overview
11.2 Middle East and Africa
- 11.2.1 Middle East & Africa ELISA Diagnostics Tests Market Breakdown, by Key
Country, 2023 and 2030 (%)
- 11.2.1.1 Middle East & Africa ELISA Diagnostics Tests Market – Revenue and
Forecast Analysis – by Country
- 11.2.1.1 South Africa:
Middle East & Africa ELISA Diagnostics Tests Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.1.1 South Africa: Middle East & Africa ELISA Diagnostics Tests Market Breakdown, by Adoption
- 11.2.1.1.2 South Africa: Middle East & Africa ELISA Diagnostics Tests Market Breakdown, by Test Type
- 11.2.1.1.3 South Africa: Middle East & Africa ELISA Diagnostics Tests Market Breakdown, by Application
- 11.2.1.1.4 South Africa: Middle East & Africa ELISA Diagnostics Tests Market Breakdown, by End User
- 11.2.1.2 Saudi Arabia:
Middle East & Africa ELISA Diagnostics Tests Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.2.1 Saudi Arabia: Middle East & Africa ELISA Diagnostics Tests Market Breakdown, by Adoption
- 11.2.1.2.2 Saudi Arabia: Middle East & Africa ELISA Diagnostics Tests Market Breakdown, by Test Type
- 11.2.1.2.3 Saudi Arabia: Middle East & Africa ELISA Diagnostics Tests Market Breakdown, by Application
- 11.2.1.2.4 Saudi Arabia: Middle East & Africa ELISA Diagnostics Tests Market Breakdown, by End User
- 11.2.1.3 UAE:
Middle East & Africa ELISA Diagnostics Tests Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.3.1 UAE: Middle East & Africa ELISA Diagnostics Tests Market Breakdown, by Adoption
- 11.2.1.3.2 UAE: Middle East & Africa ELISA Diagnostics Tests Market Breakdown, by Test Type
- 11.2.1.3.3 UAE: Middle East & Africa ELISA Diagnostics Tests Market Breakdown, by Application
- 11.2.1.3.4 UAE: Middle East & Africa ELISA Diagnostics Tests Market Breakdown, by End User
- 11.2.1.4 Rest of Middle East and Africa:
Middle East & Africa ELISA Diagnostics Tests Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.4.1 Rest of Middle East and Africa: Middle East & Africa ELISA Diagnostics Tests Market Breakdown, by Adoption
- 11.2.1.4.2 Rest of Middle East and Africa: Middle East & Africa ELISA Diagnostics Tests Market Breakdown, by Test Type
- 11.2.1.4.3 Rest of Middle East and Africa: Middle East & Africa ELISA Diagnostics Tests Market Breakdown, by Application
- 11.2.1.4.4 Rest of Middle East and Africa: Middle East & Africa ELISA Diagnostics Tests Market Breakdown, by End User
12. Competitive Landscape
12.1 Heat Map Analysis
12.2 Company Positioning and Concentration
13. Industry Landscape
13.1 Overview
13.2 Market Initiative
13.3 Partnerships and Collaborations
13.4 Other Developments
14. Company Profiles
14.1 Bio-Rad Laboratories Inc.
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Idexx Laboratories Inc.
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 F. Hoffmann-La Roche Ltd.
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 Thermo Fisher Scientific Inc.
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 Abbott Laboratories
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 Danaher Corp.
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 DiaSorin SpA
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 Elabscience Biotechnology Inc.
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
15. Appendix
15.1 About Business Market Insights
15.2 List of Abbreviations